Filter the latest scan's published facts — sector, size, yield, valuation — or rank them with a preset: cheapest, fastest growing, most profitable. Every view shows what is in the filings and prices; none ranks opportunity. The model behind the statuses showed no predictive power, and nothing here is a recommendation.
Scan of 2026-08-31 · 2,409 names scored · prices as of that date
285 names match — page 1 of 3 · Export CSV
| Ticker | Company | Sector | Market cap ↑ | P/E | P/B | Div. yield | 1M change | Composite %ile | Status |
|---|---|---|---|---|---|---|---|---|---|
| NXTC | NextCure, Inc. Common Stock | Pharma & chemicals | $23.05M | — |
Figures are as of the scan date, from unadjusted prices and point-in-time filings. "—" means the scan published no figure — deliberately, where a ratio's denominator made it meaningless. A hole is honest; a confidently wrong number is not. "Composite %ile" is the position in a ranking with no measurable predictive power — context for the status, not a score.
Never the absolute multiple alone. A P/E of 9 is a fact; whether it is low depends on what you hold it against.
The five-year window is the empirically privileged one. Cheap against its sector and cheap against its own history are different claims, and a stock can be one without being the other — which is the whole reason both columns are shown rather than blended into a single score.
| 0.86 |
| — |
| up 54.16% |
| 3.2 |
pass |
| SPRB | Spruce Biosciences, Inc. Common Stock | Pharma & chemicals | $80.92M | — | 2.34 | — | up 37.68% | 17.7 | pass |
| PTHS | Pelthos Therapeutics Inc. | Pharma & chemicals | $81.15M | — | 2.31 | — | down 15.98% | 8.8 | pass |
| CUE | Cue Biopharma, Inc. | Pharma & chemicals | $83.08M | — | 3.84 | — | down 4.92% | 4.2 | pass |
| VTVT | vTv Therapeutics Inc. Class A Common Stock | Pharma & chemicals | $126.04M | — | 1.40 | — | down 1.08% | 27.3 | pass |
| UNCY | Unicycive Therapeutics, Inc. Common Stock | Pharma & chemicals | $131.24M | — | 3.48 | — | up 3.79% | 8.0 | pass |
| LENZ | LENZ Therapeutics, Inc. Common Stock | Pharma & chemicals | $163.36M | — | 0.66 | — | down 1.70% | 4.0 | pass |
| KRRO | Korro Bio, Inc. Common Stock | Pharma & chemicals | $180.14M | — | 1.51 | — | up 20.44% | 1.4 | pass |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | Pharma & chemicals | $193.53M | — | 1.53 | — | up 21.63% | 5.1 | pass |
| DTIL | Precision BioSciences, Inc. Common Stock | Pharma & chemicals | $197.16M | — | 2.59 | — | up 9.30% | 14.4 | pass |
| ANTX | AN2 Therapeutics, Inc. Common Stock | Pharma & chemicals | $199.72M | — | 2.44 | — | up 3.74% | 20.3 | pass |
| TNXP | Tonix Pharmaceuticals Holding Corp. | Pharma & chemicals | $200.30M | — | 0.88 | — | up 40.86% | 3.7 | pass |
| ACOG | Alpha Cognition Inc. Common Stock | Pharma & chemicals | $201.85M | — | 3.51 | — | up 11.96% | 6.8 | pass |
| DERM | Journey Medical Corporation Common Stock | Pharma & chemicals | $202.54M | — | 6.57 | — | up 16.33% | 4.1 | pass |
| ORMP | Oramed Pharmaceuticals Inc. | Pharma & chemicals | $205.45M | 3.2 | 1.03 | — | up 23.34% | 98.6 | watch |
| IMUX | Immunic, Inc. Common Stock | Pharma & chemicals | $215.22M | — | 1.42 | — | up 13.10% | 20.5 | pass |
| QTTB | Q32 Bio Inc. Common Stock | Pharma & chemicals | $217.54M | 7.3 | 4.70 | — | down 5.17% | 79.9 | pass |
| KROS | Keros Therapeutics, Inc. Common Stock | Pharma & chemicals | $218.64M | 2.5 | 0.77 | — | up 10.03% | 62.9 | pass |
| GLSI | Greenwich LifeSciences, Inc. | Pharma & chemicals | $219.26M | — | 41.60 | — | up 10.74% | 3.3 | pass |
| RNA | Atrium Therapeutics, Inc. Common Stock | Pharma & chemicals | $227.85M | — | 0.97 | — | up 17.36% | 45.6 | pass |
| FF | Future Fuel Corporation | Pharma & chemicals | $231.16M | — | 1.63 | 3.61% | up 6.46% | 22.3 | pass |
| NATR | Nature's Sunshine Products Inc. | Pharma & chemicals | $248.53M | 32.3 | 1.49 | — | down 29.78% | 42.9 | pass |
| USNA | USANA Health Sciences Inc | Pharma & chemicals | $263.20M | 24.5 | 0.48 | — | down 35.50% | 25.0 | pass |
| LTBR | Lightbridge Corp. | Pharma & chemicals | $263.55M | — | 1.21 | — | down 8.62% | 4.7 | pass |
| SION | Sionna Therapeutics, Inc. Common Stock | Pharma & chemicals | $271.81M | — | 0.94 | — | down 87.21% | 25.5 | pass |
| TRDA | Entrada Therapeutics, Inc. Common Stock | Pharma & chemicals | $273.69M | — | 1.01 | — | up 3.83% | 12.4 | pass |
| ARTV | Artiva Biotherapeutics, Inc. Common Stock | Pharma & chemicals | $279.30M | — | 3.18 | — | up 11.88% | 15.6 | pass |
| EBS | Emergent Biosolutions, Inc. | Pharma & chemicals | $315.98M | — | 0.60 | — | down 15.51% | 7.2 | pass |
| VNDA | Vanda Pharmaceuticals Inc. | Pharma & chemicals | $324.73M | — | 1.16 | — | up 5.88% | 8.8 | pass |
| ABEO | Abeona Therapeutics Inc. Common Stock | Pharma & chemicals | $332.67M | 4.7 | 2.30 | — | down 8.88% | 62.0 | pass |
| LYEL | Lyell Immunopharma, Inc. Common Stock | Pharma & chemicals | $334.06M | — | 1.22 | — | up 10.66% | 10.4 | pass |
| SGMT | Sagimet Biosciences Inc. Series A Common Stock | Pharma & chemicals | $334.32M | — | 3.26 | — | up 44.30% | 3.9 | pass |
| OEC | Orion S.A. | Pharma & chemicals | $351.87M | — | 0.93 | 1.28% | down 7.56% | 7.1 | pass |
| PRLD | Prelude Therapeutics Incorporated | Pharma & chemicals | $352.90M | — | 5.86 | — | up 21.74% | 11.8 | pass |
| UPB | Upstream Bio, Inc. Common Stock | Pharma & chemicals | $360.26M | — | 1.19 | — | up 4.91% | 2.5 | pass |
| TKNO | Alpha Teknova, Inc. Common Stock | Pharma & chemicals | $384.92M | — | 5.93 | — | up 43.60% | 7.7 | pass |
| ENTA | Enanta Pharmaceuticals, Inc | Pharma & chemicals | $387.38M | — | 3.32 | — | up 5.79% | 10.7 | pass |
| BNTC | Benitec Biopharma Inc. Common Stock | Pharma & chemicals | $418.09M | — | 2.28 | — | up 3.93% | 8.6 | pass |
| ARCT | Arcturus Therapeutics Holdings Inc. Common Stock | Pharma & chemicals | $419.52M | — | 2.19 | — | up 156.25% | 1.6 | pass |
| DNA | Ginkgo Bioworks Holdings, Inc. | Pharma & chemicals | $419.91M | — | 0.95 | — | down 15.82% | 3.3 | pass |
| BIOA | BioAge Labs, Inc. Common Stock | Pharma & chemicals | $421.67M | — | 1.11 | — | up 5.09% | 26.0 | pass |
| ACHV | Achieve Life Sciences, Inc. | Pharma & chemicals | $422.73M | — | 39.59 | — | up 23.68% | 9.3 | pass |
| FENC | Fennec Pharmaceuticals Inc. Common Stock | Pharma & chemicals | $426.58M | — | 11.32 | — | up 29.05% | 6.8 | pass |
| AVIR | Atea Pharmaceuticals, Inc. Common Stock | Pharma & chemicals | $428.14M | — | 1.83 | — | up 13.83% | 23.4 | pass |
| ASIX | AdvanSix Inc. | Pharma & chemicals | $453.18M | 9.2 | 0.57 | 3.81% | down 16.20% | 47.2 | pass |
| CBIO | Crescent Biopharma, Inc. Common Stock | Pharma & chemicals | $457.69M | — | 2.49 | — | up 14.72% | 5.2 | pass |
| LXFR | Luxfer Holdings PLC Ordinary Shares | Pharma & chemicals | $459.59M | 59.7 | 2.06 | 3.03% | up 0.88% | 50.0 | pass |
| AURA | Aura Biosciences, Inc. Common Stock | Pharma & chemicals | $460.60M | — | 4.29 | — | up 2.43% | 8.0 | pass |
| PBYI | PUMA BIOTECHNOLOGY INC | Pharma & chemicals | $463.51M | 14.9 | 3.61 | — | up 14.88% | 75.9 | pass |
| NRC | NRC Health Common Stock | Pharma & chemicals | $471.92M | 40.7 | 34.97 | 2.87% | up 7.33% | 56.4 | pass |
| AVTX | Avalo Therapeutics, Inc. Common Stock | Pharma & chemicals | $476.50M | — | 6.97 | — | up 5.97% | 12.0 | pass |
| RGNX | REGENXBIO Inc. | Pharma & chemicals | $490.36M | — | 23.26 | — | down 1.96% | 2.0 | pass |
| PRTA | Prothena Corporation plc Ordinary Shares | Pharma & chemicals | $496.27M | — | 1.59 | — | up 15.15% | 11.5 | pass |
| KYTX | Kyverna Therapeutics, Inc. Common Stock | Pharma & chemicals | $513.01M | — | 2.62 | — | up 16.10% | 16.0 | pass |
| ZURA | Zura Bio Limited Class A Ordinary Shares | Pharma & chemicals | $525.64M | — | 5.18 | — | up 2.03% | 15.1 | pass |
| STTK | Shattuck Labs, Inc. Common Stock | Pharma & chemicals | $529.83M | — | 5.53 | — | down 0.85% | 17.6 | pass |
| ASMB | Assembly Biosciences, Inc | Pharma & chemicals | $534.46M | — | 2.69 | — | up 33.93% | 13.2 | pass |
| TECX | Tectonic Therapeutic, Inc. Common Stock | Pharma & chemicals | $563.78M | — | 2.45 | — | up 6.81% | 7.8 | pass |
| NGNE | Neurogene, Inc. Common Stock | Pharma & chemicals | $565.92M | — | 2.38 | — | up 10.19% | 19.4 | pass |
| CAPR | Capricor Therapeutics Inc | Pharma & chemicals | $571.46M | — | 2.05 | — | up 157.40% | 1.6 | pass |
| ARVN | Arvinas, Inc | Pharma & chemicals | $593.40M | — | 1.53 | — | up 14.57% | 14.7 | pass |
| SPRY | ARS Pharmaceuticals, Inc. Common Stock | Pharma & chemicals | $595.80M | — | 9.72 | — | up 16.96% | 0.3 | pass |
| NVCT | Nuvectis Pharma, Inc. Common Stock | Pharma & chemicals | $602.93M | — | 42.40 | — | up 5.62% | 12.5 | pass |
| CTNM | Contineum Therapeutics, Inc. Class A Common Stock | Pharma & chemicals | $607.15M | — | 2.43 | — | up 4.84% | 22.1 | pass |
| VSTM | Verastem, Inc. | Pharma & chemicals | $634.23M | — | 7.76 | — | up 24.48% | 0.8 | pass |
| CRMD | CorMedix Inc. | Pharma & chemicals | $647.55M | 4.0 | 1.48 | — | up 9.69% | 48.2 | pass |
| CLYM | Climb Bio, Inc. Common Stock | Pharma & chemicals | $655.86M | — | 4.43 | — | up 15.38% | 19.1 | pass |
| ZVRA | Zevra Therapeutics, Inc. Common Stock | Pharma & chemicals | $694.01M | 8.3 | 3.37 | — | up 23.45% | 56.0 | pass |
| BBOT | BridgeBio Oncology Therapeutics, Inc. Common Stock | Pharma & chemicals | $704.78M | — | 1.89 | — | up 8.78% | 6.0 | pass |
| FDMT | 4D Molecular Therapeutics, Inc. Common Stock | Pharma & chemicals | $737.55M | — | 1.63 | — | up 38.61% | 21.8 | pass |
| IMMX | Immix Biopharma, Inc. Common Stock | Pharma & chemicals | $743.76M | — | 8.82 | — | up 68.63% | 17.7 | pass |
| MNPR | Monopar Therapeutics Inc. Common Stock | Pharma & chemicals | $749.83M | — | 5.54 | — | up 3.30% | 25.7 | pass |
| COLL | Collegium Pharmaceutical, Inc. Common Stock | Pharma & chemicals | $797.54M | 12.7 | 2.55 | — | down 30.46% | 57.2 | pass |
| CYRX | CryoPort, Inc. Common Stock | Pharma & chemicals | $803.17M | 10.3 | 1.62 | — | up 6.03% | 87.2 | pass |
| TROX | TRONOX LIMITED CL A ORDINARY SHARES | Pharma & chemicals | $843.85M | — | 0.65 | 3.78% | down 9.42% | 23.3 | pass |
| ACRS | Aclaris Therapeutics, Inc. | Pharma & chemicals | $844.90M | — | 5.88 | — | up 16.35% | 16.3 | pass |
| RIGL | Rigel Pharmaceuticals Inc. (New) | Pharma & chemicals | $845.60M | 2.3 | 2.11 | — | up 25.45% | 58.6 | pass |
| FTK | Flotek Industries, Inc. | Pharma & chemicals | $858.06M | 28.1 | 7.26 | — | up 0.76% | 59.3 | pass |
| TBPH | Theravance Biopharma, Inc. | Pharma & chemicals | $877.82M | 8.3 | 3.02 | — | up 1.07% | 81.7 | pass |
| OLMA | Olema Pharmaceuticals, Inc. Common Stock | Pharma & chemicals | $910.88M | — | 1.90 | — | down 8.91% | 20.1 | pass |
| DSGN | Design Therapeutics, Inc. Common Stock | Pharma & chemicals | $942.24M | — | 4.32 | — | up 23.89% | 20.0 | pass |
| SLDB | Solid Biosciences Inc. Common Stock | Pharma & chemicals | $942.62M | — | 2.52 | — | up 18.86% | 14.5 | pass |
| CADL | Candel Therapeutics, Inc. Common Stock | Pharma & chemicals | $957.48M | — | 6.94 | — | up 30.57% | 17.5 | pass |
| LXU | LSB INDUSTRIES INC | Pharma & chemicals | $972.76M | 39.5 | 1.79 | — | down 1.93% | 40.1 | pass |
| QDEL | QuidelOrtho Corporation Common Stock | Pharma & chemicals | $982.68M | — | 0.53 | — | down 13.95% | 3.8 | pass |
| ABUS | Arbutus Biopharma Corporation Common Stock | Pharma & chemicals | $1.00B | — | 3.85 | — | up 17.05% | 20.6 | pass |
| AMPH | Amphastar Pharmaceuticals, Inc. | Pharma & chemicals | $1.01B | 10.3 | 1.30 | — | up 12.99% | 44.4 | pass |
| GPRE | Green Plains, Inc. | Pharma & chemicals | $1.01B | — | 1.29 | — | down 14.24% | 29.2 | pass |
| KRO | Kronos Worldwide, Inc. | Pharma & chemicals | $1.01B | — | 1.36 | 2.27% | up 46.51% | 13.0 | pass |
| PCRX | Pacira BioSciences, Inc. Common Stock | Pharma & chemicals | $1.02B | 144.7 | 1.56 | — | down 1.93% | 33.3 | pass |
| JBIO | Jade Biosciences, Inc. Common Stock | Pharma & chemicals | $1.05B | — | 3.56 | — | up 8.15% | 21.2 | pass |
| MLTX | MoonLake Immunotherapeutics Class A Ordinary Shares | Pharma & chemicals | $1.09B | — | 4.27 | — | down 18.38% | 0.5 | pass |
| SVRA | Savara Inc. | Pharma & chemicals | $1.10B | — | 6.27 | — | down 1.28% | 20.2 | pass |
| JANX | Janux Therapeutics, Inc. Common Stock | Pharma & chemicals | $1.11B | — | 1.18 | — | up 20.11% | 6.4 | pass |
| ECVT | Ecovyst Inc. | Pharma & chemicals | $1.11B | — | 1.94 | — | down 15.67% | 40.8 | pass |
| KURA | Kura Oncology, Inc. | Pharma & chemicals | $1.12B | — | 10.41 | — | up 40.40% | 5.3 | pass |
| GLUE | Monte Rosa Therapeutics, Inc. Common Stock | Pharma & chemicals | $1.18B | — | 2.25 | — | down 15.62% | 29.0 | pass |
| CRVS | Corvus Pharmaceuticals, Inc. | Pharma & chemicals | $1.18B | — | 4.91 | — | up 5.88% | 22.1 | pass |
| PCT | PureCycle Technologies, Inc. Common stock | Pharma & chemicals | $1.18B | — | — | — | up 2.51% | 0.2 | pass |
| ANRO | Alto Neuroscience Inc. | Pharma & chemicals | $1.24B | — | 5.10 | — | up 30.70% | 19.3 | pass |